300+ leading life science equity and corporate strategic investors


Who are some of the leading investors, pharma and commercial leaders most active this side of the Atlantic?

What follows is a summary of the life science industry’s most notable and active investors. They represent $bns of combined assets under management across therapeutics, diagnostics and medtech.

The selection represents a snapshot of the 300+ individuals from 250+ unique investment firms currently signed up to the 6th Annual LSX World Congress taking place 4-5 February in London. Why are they attending? Download the full programme to find out!

See the leading life science investors